Standard multiport laparoscopic adrenalectomy (LA) involves the use of typically three to five ports, depending on the complexity of the procedure. Nowadays, laparo-endoscopic single-site surgery (LESS) is exciting the scientific community because it offers the opportunity to do major laparoscopic surgery with no visible scars and with potential reduced postoperative pain and hospital stay (2) . LESS has been used for cholecystectomy (3) , appendectomy (4) and several urological surgeries (5) , but the high degree of difficulty and the longer learning curve tends to make its widespread difficult. LESS surgery through the umbilicus is the most appealing approach, as it truly avoids any new scar, with the multichannel port being placed through a 1.5 to 2 cmincision at the deep edge of the obliterated embryonic orifice. Partial adrenalectomy has been a promising surgical technique mainly in functioning lesion in a solitary adrenal gland or in bilateral hereditary or sporadic tumors with the goal of reducing endocrinopathy. However, it has a relapse risk that we always have to remember (6) . Here, we present our experience with transumbilical LESS adrenalectomy comparing with standard multiport laparoscopic multiport, showing our results with partial adrenalectomy too.
MATERIAL AND METHODS
Between March 2009 and June 2017, 100 adrenal glands from 93 patients underwent transperitoneal laparoscopic adrenalectomy at the Urology and Renal Transplantation Department of Coimbra University Hospital Center: 59 (59%) underwent standard multi-port laparoscopy (group 1) and 41 (41%) underwent transumbilical laparo-endoscopic single-site adrenalectomy (group 2). Standard multi-port laparoscopy included three to four ports. The multichannel port (Triport) and bent laparoscopic instruments were supplied by Olympus Surgical (KeyMed House, Stock Road, United Kingdom). The multichannel port was placed through a 2-cm incision at the inner edge of the umbilicus and a bent instrument on the left hand was used to create the operative angle. In 30% of cases, it was needed a forceps with no port to move the liver away from the operative field. All transumbilical laparoendoscopic single-site adrenalec-
INTRODUCTION
The first laparoscopic adrenalectomy was performed by Gagner et al. (1) in 1992 and, since then, it has become the gold standard procedure for most adrenal tumors.
tomies were executed by one surgeon while standard LA were performed by more than one surgeon. Data gathered included demographics, comorbidities, preoperative imaging, tumor characteristics, perioperative data, surgical complications, length of stay, need for analgesia, pathology and follow-up. All patients were evaluated by the Endocrinology team with a standard protocol. Written informed consent was obtained from all patients and the study was performed according to the Declaration of Helsinki. Data were collected retrospectively and processed with IBM SPSS Statistics 23 software. Groups were compared using the chi-square test and t Student test for categorical and continuous variables, respectively. Survival analysis was done through Kaplan-Meyer survival curve. Statistical significance was set at p value of < 0.05, and all reported p-values are two-sided.
RESULTS
Patient demographic data are shown in Table 1 . Patients elected for transumbilical LESS adrenalectomy were younger and with less comorbidities. Preoperative tumor data are shown at Table 2 . The laterality of the lesion didn't have any impact in the choice of the surgical technique. 52.5% of the cases submitted to standard multi-port LA were incidentally diagnosed nonfunctioning enlarged adrenals. In group 2, arterial hypertension was the main initial symptom and elevated aldosterone was the most common finding. Only 24.4% of the tumors submitted to transumbilical LESS adrenalectomy were non-functioning. Perioperative data are shown in Table 3 . There was no difference between groups concerning operative time and estimated blood loss. 29.3% of transumbilical LESS surgeries were partial adrenalectomies: no one was done by standard multi-port laparoscopy. Seven (7%) patients were submitted to bilateral adrenalectomies, two by multi-port LA and five by transumbilical LESS technique. Drainage was placed in a minority of cases submitted to transumbilical LESS technique while the majority of patients submitted to standard multi-port laparoscopy underwent drainage placement. One case of multi-port LA was converted to open surgery due to the absence of surgical plans in a lesion that revealed to be posteriorly a melanoma metastasis. There were four perioperative complications, all of them during or after a standard multi-port laparoscopic adrenalectomy. There was no difference concerning postoperative opioid analgesic requirement and hospital length of stay. The hospital length of stay was mainly conditioned by medical or hormonal issues more than the surgery itself. However, the time to resume normal diet was lower in group 2. There were neither reoperations nor perioperative mortality and the tumor laterality did not influence surgical morbidity (p > 0.05). Transumbilical LESS technique allowed for a completely hidden scar in all cases, with excellent cosmesis. The final pathology is shown in Table 4 . The mean pathological diameter was inferior in the group 2 and, in both groups, benign adenoma was the most common diagnosis. In the next table (Table 5) , there is a brief summary on our experience with partial adrenalectomy. All of them were submitted to transumbilical LESS technique and all lesions were hormone producing. More than half were bilateral and presented mostly with symptoms of Cushing disease and arterial hypertension. The pathological data revealed mainly adenoma and cortical hyperplasia. Overall mean follow-up time was 94.9 ± 3.1 months (group 1 = 92.1 ± 5.7 months versus group 2 = 95.6 ± 2.4 months with no statistically difference between groups, p = 0.7), as shown in Figure 1 .
DISCUSSION
Laparoendoscopic single-site adrenalectomy is a minimally invasive surgical technique that is being increasingly used. Transumbilical route offers the opportunity to remove the adrenal gland or only the adrenal tumor with only one hidden incision. Therefore, the level of patient with the scar cosmetics is expected to be better. The high degree of difficulty and the alleged longer surgical learning curve makes this surgical approach only feasible for experienced laparoscopic surgeons. In our institution, a single urologist performed the transumbilical laparoendoscopic single-site adrenalectomies and standard laparoscopic adrenalectomies were executed by several urologists. The reduced drainage need and the faster recovery of normal diet in transumbilical LESS adrenalectomies could be biased for that reason. LESS approach can be implemented in partial adrenalectomy (10) . We started to do partial adrenalectomy and all of them were done by transumbilical LESS technique and all were hormonal active adrenal tumors. During the last years, partial adrenalectomy has been accepted for adrenal tumors in unilateral glands or in patients with hereditary syndromes. Our experience is limited, the follow-up is short to see if there is any relapse and only two patients are not corticoid-free of medical therapy. Partial adrenalectomy is especially done in Conn' s syndrome and in pheochromocytoma. In our series, no pheochromocytoma was submitted to partial adrenalectomy probably because of the multifocal nature of the disease that could explain the relatively high recurrence rate in hereditary pheochromocytoma (10) and for that reason we did not perform partial adrenalectomies in these patients. Nagaraja et al. (6) found that the overall recurrence rate was 8% and 85% of the patients were steroid-free. In our series, no relapse was found and 83.3% of patients did not need any substitutive therapeutic after surgery. More experience and more time are needed to evaluate if this technique could be a good alternative to total adrenalectomy. Although LESS partial adrenalectomy may be a well-tolerated and feasible procedure to reduce endocrinopathy, studies proving long-term outcome and controlled trials are missing: earlier publications suggested that only one-third of one gland is sufficient to avoid hormonal deficiency (6) .
CONCLUSIONS
Transumbilical approach for laparoendoscopic single-site adrenalectomy for adrenal tumours could be a good alternative to standard laparoscopic adrenalectomy. Our results showed similar perioperative data, less drainage, quicker return to normal diet and with no reoperations or perioperative mortality.
